Dayanand Bagdure
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Dayanand Bagdure has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Adnan T. Bhutta
University of Arkansas Medical Center
2 shared publications Girija R. Bhoite
2 shared publicationsJason W. Custer
Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, United States
2 shared publicationsArleta Rewers
Department of Pediatrics; University of Colorado School of Medicine; Section of Emergency Medicine; Children's Hospital Colorado; Aurora; CO; 80045; USA
1 shared publicationBrandon W. Beam
Division of Pediatric Cardiology, Department of Pediatrics, Informatics, Arkansas Children's Hospital, Little Rock, Arkansas
1 shared publicationElizabeth Campagna
Children's Outcome Research Program; University of Colorado School of Medicine; Aurora; CO; 80045; USA
1 shared publication
Latest Publications
- 6 February 2017
- Published by Georg Thieme Verlag KG in Journal of Pediatric Intensive Care
- Vol. 06 (03) , 188-193
Extracorporeal Membrane Oxygenation for Neonates with Congenital Renal and Urological Anomalies and Pulmonary Hypoplasia: A Case Report and Review of the Extracorporeal Life Support Organization Registry
Objective Congenital anomalies of the kidney and urinary tract constitute up to 30% of anomalies identified in the neonatal period. In utero oligohydramnios is often associated with pulmonary hypoplasia and respiratory failure in the neonate who may not be responsive to mechanical ventilation. Placement of these neonates on extracorporeal membrane oxygenation (ECMO) remains controversial and is considered in most centers to be a relative contraindication. The objective of this study is to use the Extracorporeal Life Support Organization (ELSO) database to describe the outcomes and complications of patients with congenital renal and urogenital anomalies with pulmonary hypoplasia who underwent ECMO in the neonatal period. Data Sources Data from the ELSO registry were retrospectively reviewed for all patients with congenital renal and urogenital anomalies with pulmonary hypoplasia treated with ECMO support between 1990 and November 2014 using ICD-9 diagnosis codes. Data Synthesis We identified 45 patients. The average age of the patient at the time of ECMO was 1.7 days (range: 0–14 days) and weight was 3.1 kg (interquartile range [IQR]: 2.5–3.3). Patients spent an average of 162 hours on ECMO (IQR: 81–207). The majority of patients were managed with venoarterial ECMO (60%), and the overall survival of this cohort was 42%. Survivors had higher weights (3.4 vs. 2.8 kg; p < 0.019) and were more likely to be male (90 vs. 44%; p < 0.002). Patients with obstructive urogenital lesions had an overall survival of 71 versus 16.6% in patients with a primary intrinsic renal diagnosis (p = 0.004). Renal replacement therapy was required in 51% of the patients during their ECMO support. Conclusion Neonates with renal or urogenital disease and pulmonary hypoplasia have an overall survival rate of 42%. Patients with a diagnosis of urogenital obstruction have much more favorable outcomes when compared with those with intrinsic renal disease such as polycystic kidney disease.
- 6 February 2017
- Published by Georg Thieme Verlag KG in Journal of Pediatric Intensive Care
- Vol. 06 (03) , 188-193
Extracorporeal Membrane Oxygenation for Neonates with Congenital Renal and Urological Anomalies and Pulmonary Hypoplasia: A Case Report and Review of the Extracorporeal Life Support Organization Registry
Objective Congenital anomalies of the kidney and urinary tract constitute up to 30% of anomalies identified in the neonatal period. In utero oligohydramnios is often associated with pulmonary hypoplasia and respiratory failure in the neonate who may not be responsive to mechanical ventilation. Placement of these neonates on extracorporeal membrane oxygenation (ECMO) remains controversial and is considered in most centers to be a relative contraindication. The objective of this study is to use the Extracorporeal Life Support Organization (ELSO) database to describe the outcomes and complications of patients with congenital renal and urogenital anomalies with pulmonary hypoplasia who underwent ECMO in the neonatal period. Data Sources Data from the ELSO registry were retrospectively reviewed for all patients with congenital renal and urogenital anomalies with pulmonary hypoplasia treated with ECMO support between 1990 and November 2014 using ICD-9 diagnosis codes. Data Synthesis We identified 45 patients. The average age of the patient at the time of ECMO was 1.7 days (range: 0–14 days) and weight was 3.1 kg (interquartile range [IQR]: 2.5–3.3). Patients spent an average of 162 hours on ECMO (IQR: 81–207). The majority of patients were managed with venoarterial ECMO (60%), and the overall survival of this cohort was 42%. Survivors had higher weights (3.4 vs. 2.8 kg; p < 0.019) and were more likely to be male (90 vs. 44%; p < 0.002). Patients with obstructive urogenital lesions had an overall survival of 71 versus 16.6% in patients with a primary intrinsic renal diagnosis (p = 0.004). Renal replacement therapy was required in 51% of the patients during their ECMO support. Conclusion Neonates with renal or urogenital disease and pulmonary hypoplasia have an overall survival rate of 42%. Patients with a diagnosis of urogenital obstruction have much more favorable outcomes when compared with those with intrinsic renal disease such as polycystic kidney disease.
- 1 August 2016
- Published by Elsevier in Pediatric Neurology
- Vol. 61, 58-62
Hospitalized Children With Encephalitis in the United States: A Pediatric Health Information System Database Study
- 1 August 2016
- Published by Elsevier in Pediatric Neurology
- Vol. 61, 58-62
Hospitalized Children With Encephalitis in the United States: A Pediatric Health Information System Database Study
- 28 August 2012
- Published by Hindawi Limited in Pediatric Diabetes
- Vol. 14 (1) , 18-24
Epidemiology of hyperglycemic hyperosmolar syndrome in children hospitalized in USA
Background Previous studies of hyperglycemic hyperosmolar syndrome (HHS) in children are limited to case series or single-institution reviews, which describe HHS primarily in children with type 2 diabetes mellitus. Objective To estimate the incidence and describe the epidemiologic characteristics of HHS among children in USA. Subjects All discharges in the Kids' Inpatient Database – a triennial, nationwide, stratified probability sample of hospital discharges for years 1997–2009 – with age 0–18 yr and a diagnosis of HHS. Methods Using sample weights, we calculated the incidence and population rate of hospitalization with a diagnosis of HHS. Results Our sample included 1074 HHS hospitalizations; of these, 42.9% were 16–18 yr, 70.6% had type 1 diabetes (T1D), and 53.0% had major or extreme severity of illness. The median length of stay was 2.6 d, 2.7% of hospitalizations ended in death, and median hospital charge was $10 882. When comparing HHS hospitalizations by diabetes type, the proportion with T1D fell steadily with age, from 89.1% among children 0–9 yr, to 65.1% in 16–18 yr olds. Patients with T1D had a shorter length of stay by 0.9 d, and had a lower median charge by $5311. There was no difference in mortality by diabetes type. Population rates for HHS hospitalization rose 52.4% from 2.1 to 3.2 per 1 000 000 children from 1997 to 2009. Conclusion Hospitalizations for a diagnosis of HHS have high morbidity and are increasing in incidence since 1997. In contrast to prior reports, we found a substantial percentage of HHS hospitalizations occurred among children with T1D.
- 28 August 2012
- Published by Hindawi Limited in Pediatric Diabetes
- Vol. 14 (1) , 18-24
Epidemiology of hyperglycemic hyperosmolar syndrome in children hospitalized in USA
Background Previous studies of hyperglycemic hyperosmolar syndrome (HHS) in children are limited to case series or single-institution reviews, which describe HHS primarily in children with type 2 diabetes mellitus. Objective To estimate the incidence and describe the epidemiologic characteristics of HHS among children in USA. Subjects All discharges in the Kids' Inpatient Database – a triennial, nationwide, stratified probability sample of hospital discharges for years 1997–2009 – with age 0–18 yr and a diagnosis of HHS. Methods Using sample weights, we calculated the incidence and population rate of hospitalization with a diagnosis of HHS. Results Our sample included 1074 HHS hospitalizations; of these, 42.9% were 16–18 yr, 70.6% had type 1 diabetes (T1D), and 53.0% had major or extreme severity of illness. The median length of stay was 2.6 d, 2.7% of hospitalizations ended in death, and median hospital charge was $10 882. When comparing HHS hospitalizations by diabetes type, the proportion with T1D fell steadily with age, from 89.1% among children 0–9 yr, to 65.1% in 16–18 yr olds. Patients with T1D had a shorter length of stay by 0.9 d, and had a lower median charge by $5311. There was no difference in mortality by diabetes type. Population rates for HHS hospitalization rose 52.4% from 2.1 to 3.2 per 1 000 000 children from 1997 to 2009. Conclusion Hospitalizations for a diagnosis of HHS have high morbidity and are increasing in incidence since 1997. In contrast to prior reports, we found a substantial percentage of HHS hospitalizations occurred among children with T1D.
- 5 May 2012
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 80 (4) , 343-344
Dexmedetomidine in a Child with Methylphenidate Intoxication
Methylphenidate intoxication, due to accidental ingestion, is a common occurrence in pediatrics. Symptoms of extreme agitation are typically controlled with benzodiazepines or barbiturates. There is, however, a legitimate risk of mechanical ventilation due to respiratory depression with increasing doses of benzodiazepines. The authors describe a case of 7-y-old girl with methylphenidate toxicity where dexmedetomidine was successfully used to manage agitation and cardiovascular stimulation without respiratory compromise.
- 5 May 2012
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 80 (4) , 343-344
Dexmedetomidine in a Child with Methylphenidate Intoxication
Methylphenidate intoxication, due to accidental ingestion, is a common occurrence in pediatrics. Symptoms of extreme agitation are typically controlled with benzodiazepines or barbiturates. There is, however, a legitimate risk of mechanical ventilation due to respiratory depression with increasing doses of benzodiazepines. The authors describe a case of 7-y-old girl with methylphenidate toxicity where dexmedetomidine was successfully used to manage agitation and cardiovascular stimulation without respiratory compromise.